Intra-arterial administration of bone marrow-derived mesenchymal stem cells delivered six hours after transient focal cerebral ischemia significantly mitigates neurological impairment, reduces cerebral infarction, suppresses oxidative injury, and reconfigures endoplasmic reticulum architecture in an adult rat model of ischemic stroke. In an experimental investigation published in Molecular Brain, researchers established that targeted endovascular infusion of stem cells into the internal carotid artery preserves the structural integrity of the endoplasmic reticulum network within penumbral cortical brain tissue. This restorative cascade operates through modulation of the GRP78, atlastin, and CHOP signaling axis, counteracting disruptions in calcium homeostasis that culminate in cellular degeneration following arterial occlusion. Male Sprague-Dawley rats subjected to ninety minutes of middle cerebral artery occlusion and treated with mesenchymal stem cells exhibited marked improvements in motor coordination, forelimb grip strength, cognitive exploratory behavior, and emotional balance across fourteen days. These findings provide molecular and histological evidence demonstrating that endovascular stem cell therapy alleviates post-stroke organelle stress.
Ischemic stroke originates from an abrupt reduction in cerebral blood flow and oxygen supply, precipitating metabolic failure and enduring functional deficits. Following arterial occlusion, excessive synaptic accumulation of extracellular glutamate hyperactivates postsynaptic N-methyl-D-aspartate receptors, driving an uncontrolled influx of calcium ions into vulnerable neuronal populations. This calcium excitotoxicity triggers an intracellular cascade of neuronal injury and apoptotic death while compromising intracellular organelle systems. In healthy brain cells, the endoplasmic reticulum stores intracellular calcium and coordinates protein processing through calcium-dependent molecular chaperones. However, profound deregulation of calcium homeostasis during ischemia imposes severe endoplasmic reticulum stress, initiating the unfolded protein response and destabilizing the physiological coupling between the resident chaperone GRP78 and PERK. Unresolved organelle stress alters structural membrane proteins, including atlastin, which governs homotypic tubule fusion, and Climp63, which maintains rough endoplasmic reticulum sheets. Concurrently, elevated calcium levels promote reticulon-dependent tubule fragmentation and activate pro-apoptotic pathways, culminating in irreversible tissue destruction.
To investigate whether targeted cellular intervention could restore organelle integrity following ischemic injury, the investigative team utilized adult male Sprague-Dawley rats aged six to seven weeks with body weights between 220 and 250 grams. Animal housing adhered to standardized environmental conditions maintained at 25 ± 0.5 degrees Celsius and 60 ± 5 percent relative humidity, with ad libitum access to water and food pellets. All procedures complied with Committee for Control and Supervision of Experiments on Animals guidelines and secured formal approval from the Institutional Animal Ethics Committee under protocols NIPERA/IAEC/2022/021 and NIPERA/IAEC/2023/025. The experimental design comprised 126 animals randomized into six distinct treatment arms containing 21 subjects each: sham control, untreated stroke, stroke receiving phosphate-buffered saline, stroke treated with mesenchymal stem cells, stroke treated with the calcium channel inhibitor flunarizine, and a combination cohort receiving both flunarizine and stem cells. Unbiased researchers conducted all behavioral, biochemical, molecular, and histological evaluations, employing power calculations to verify adequate experimental sample sizes.
Surgical induction of focal cerebral ischemia was achieved through transient middle cerebral artery occlusion lasting ninety minutes under gas anesthesia with isoflurane. Physiological parameters were monitored continuously, including blood glucose and femoral arterial blood gas values for oxygen, carbon dioxide, and pH. Cortical perfusion dynamics were tracked using laser Doppler flowmetry, while near-infrared spectroscopy quantified regional cerebral oxygen saturation before, during, and after occlusion. Focal ischemia was induced by introducing a silicone-coated monofilament through the external carotid artery into the internal carotid artery, followed by filament removal after ninety minutes to allow reperfusion. Six hours post-reperfusion, animals received intra-arterial infusions of 100,000 rat bone marrow-derived mesenchymal stem cells in 0.5 milliliters of phosphate-buffered saline, administered over ten minutes through a catheter in the internal carotid artery. Pharmacological cohorts received ten milligrams per kilogram of flunarizine. Post-surgical care included four hours of heat-lamp support, buprenorphine administration, and saline rehydration to reduce postoperative distress.
Functional recovery was evaluated at post-stroke days 1, 7, and 14 using a comprehensive battery of neurobehavioral tests. Neurological deficit scoring based on a twelve-point scale—evaluating visual and tactile placement, proprioceptive stimuli, and postural reflexes—demonstrated severe impairment in untreated stroke animals, whereas administration of mesenchymal stem cells, flunarizine, or their combination significantly lowered neurological deficit scores. Motor coordination evaluated by rotarod performance at 5, 10, and 20 revolutions per minute showed that stem cell therapy significantly prolonged latency to fall compared to stroke controls at days 1 and 14. Forelimb grip strength testing using an electronic meter confirmed significant preservation of muscular force in both ipsilateral and contralateral paws following stem cell administration. Cognitive performance measured through spontaneous alternations in a Y-maze paradigm revealed marked improvements in cell-treated subjects. Furthermore, elevated plus maze testing demonstrated that stem cell and flunarizine treatments reversed post-stroke anxiety, significantly increasing exploratory time spent within open arms.
Histological and morphological analyses of brain tissue confirmed marked neuroprotection following intra-arterial stem cell delivery. Infarct volume quantification on two-millimeter coronal sections stained with 2,3,5-triphenyltetrazolium chloride showed that stem cell administration significantly reduced the unstained pale infarct area compared to untreated stroke cohorts. Microscopic examination of hematoxylin and eosin-stained penumbral cortical sections revealed that mesenchymal stem cell transplantation restored tissue architecture and attenuated microstructural disruption caused by ischemia-reperfusion injury. Cortical neuronal survival evaluated via Nissl staining with cresyl violet at days 1 and 14 showed substantial loss of viable neurons in stroke controls, whereas stem cell-treated animals retained significantly higher numbers of intact neurons. These observations were corroborated by confocal immunofluorescence assays for neuronal markers NeuN and beta-III-tubulin in vibratome sections counterstained with DAPI. Mesenchymal stem cells, flunarizine, and their combination significantly increased the percentage of NeuN-positive and TuJ1-positive cortical neurons compared to untreated stroke groups across acute and extended intervals.
Biochemical analyses of ipsilateral cortical brain tissue harvested twenty-four hours after reperfusion demonstrated that stem cell therapy effectively counteracted ischemic oxidative and nitrosative stress. Ischemic injury triggered severe oxidative damage, manifested by marked elevations in malondialdehyde concentrations measured via the thiobarbituric acid assay at 532 nanometers, indicating extensive membrane lipid peroxidation. Concurrently, nitrosative stress escalated sharply in stroke animals, as evidenced by elevated tissue nitrite concentrations measured spectrophotometrically using the Griess reaction at 540 nanometers. Intra-arterial administration of mesenchymal stem cells, flunarizine, or their combination significantly reversed these pathological disruptions, suppressing malondialdehyde and nitrite levels while restoring glutathione concentrations toward baseline values. By re-establishing intracellular redox equilibrium, stem cell intervention protected penumbral cortical neurons against oxidative degradation during the critical acute recovery phase.
To investigate the genomic mechanisms governing organelle remodeling, researchers performed quantitative real-time polymerase chain reaction on total cortical RNA harvested one day after reperfusion. Following extraction with TRIzol reagent and spectrophotometric validation, complementary DNA was synthesized and amplified using SYBR Green supermix. Transcript analysis revealed that ischemic stroke significantly downregulated essential endoplasmic reticulum fusion genes, specifically atlastin and Climp63 (CKAP4), impairing the cellular machinery that maintains branched tubular networks and rough endoplasmic reticulum sheets. In contrast, stroke tissue exhibited significant upregulation of reticulon mRNA, reflecting accelerated tubule constriction and organelle fragmentation. Treatment with intra-arterial mesenchymal stem cells or flunarizine significantly reversed these alterations, elevating atlastin and Climp63 expression while suppressing reticulon transcription. Furthermore, stroke markedly increased transcript levels of C/EBP homologous protein (CHOP), an established mediator of endoplasmic reticulum stress-induced apoptosis, whereas stem cell administration significantly decreased CHOP expression, demonstrating transcriptional suppression of organelle-driven apoptotic signaling.
Western blotting and confocal immunofluorescence microscopy substantiated that stem cell delivery restores endoplasmic reticulum structural dynamics and modulates calcium-dependent signaling at the protein level. In stroke-injured cortical tissue, immunoblotting revealed marked upregulation of the molecular chaperone GRP78 and the luminal calcium sensor calreticulin, reflecting severe organelle stress and perturbed calcium buffering. Following stem cell transplantation or flunarizine administration, protein levels of GRP78 and calreticulin decreased significantly, indicating restored calcium equilibrium. Concurrently, the calcium-binding protein S100A10, which facilitates neuroprotection, was depleted post-stroke but restored in stem cell and flunarizine cohorts. Regarding organelle morphology, stem cells elevated protein abundance of fusion markers atlastin and Climp63 while reducing the fission marker reticulon. Furthermore, stem cell treatment significantly decreased levels of pro-apoptotic CHOP, demonstrating that restoring calcium and organelle dynamics suppresses neuronal apoptosis.
The collective findings demonstrate that endovascular mesenchymal stem cell transplantation confers robust neuroprotection following ischemic stroke by restoring calcium homeostasis and preserving endoplasmic reticulum dynamics through modulation of the GRP78, atlastin, and CHOP axis. Notably, the lack of significant differences between stem cell monotherapy, flunarizine monotherapy, and their combination suggests that stem cell-mediated regulation of calcium channel flux primarily drives post-stroke neuroprotection. While these preclinical results provide mechanistic insight into organelle repair and functional recovery, the experimental scope was restricted to young adult male Sprague-Dawley rats subjected to transient middle cerebral artery occlusion. Nevertheless, demonstrating that targeted intra-arterial stem cell delivery reconfigures injured endoplasmic reticulum networks and suppresses apoptotic signaling underscores the translational potential of endovascular cell therapy as an adjunctive neuroprotective intervention for ischemic stroke.
Subject of Research: Endovascular stem cell therapy and endoplasmic reticulum dynamics in cerebral ischemia
Article Title: Endovascular stem cell therapy reconfigures post-stroke ER dynamics via GRP78/Atlastin/CHOP axis
Article References: Kumari, A., Yadav, J., Godse, P., Karmarkar, G., Dubey, A., More, A., Saha, C., Ghosh, B., Datta, A., Barik, A., Borah, A., Yavagal, D. R., & Bhattacharya, P. (2026). Endovascular stem cell therapy reconfigures post-stroke ER dynamics via GRP78/Atlastin/CHOP axis. Molecular Brain, 19(1), Article 65. https://doi.org/10.1186/s13041-026-01326-x
Image Credits: AI Generated
DOI: 10.1186/s13041-026-01326-x
Keywords: mesenchymal stem cells, ischemic stroke, endoplasmic reticulum stress, calcium homeostasis, GRP78, atlastin, CHOP, Climp63, reticulon, calreticulin, S100A10, middle cerebral artery occlusion, flunarizine, neuroprotection, oxidative stress, rotarod performance, Sprague-Dawley rats, intra-arterial therapy
News Source: Drew Townsend. (November 19, 2026). Stem Cell Delivery Repairs Post-Stroke Endoplasmic Reticulum Dynamics in Rat Model. Scienmag.



